Invesco Ltd. Procept Bio Robotics Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Invesco Ltd. holds 268,479 shares of PRCT stock, worth $25.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

268,479

Previous 51,480 421.52%

Holding current value

$25.1 Million

Previous $3.14 Million 584.06%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.31 - $84.99 $12.2 Million - $18.4 Million	216,999 Added 421.52%	268,479 $21.5 Million
Q2 2024 Aug 13, 2024	BUY	$45.73 - $69.19 $1.51 Million - $2.28 Million	32,960 Added 177.97%	51,480 $3.14 Million
Q1 2024 May 14, 2024	SELL	$40.38 - $50.75 $100,586 - $126,418	-2,491 Reduced 11.86%	18,520 $915,000
Q4 2023 Feb 12, 2024	BUY	$24.89 - $43.41 $175,648 - $306,344	7,057 Added 50.57%	21,011 $880,000
Q3 2023 Nov 13, 2023	BUY	$30.02 - $38.81 $150 - $194	5 Added 0.04%	13,954 $457,000
Q2 2023 Aug 11, 2023	BUY	$26.7 - $37.02 $80,927 - $112,207	3,031 Added 27.76%	13,949 $493,000
Q1 2023 May 12, 2023	SELL	$26.64 - $39.74 $943,402 - $1.41 Million	-35,413 Reduced 76.43%	10,918 $310,000
Q4 2022 Feb 13, 2023	SELL	$38.78 - $46.78 $3.08 Million - $3.72 Million	-79,538 Reduced 63.19%	46,331 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $2.53 Million - $4.15 Million	81,964 Added 186.68%	125,869 $5.22 Million
Q2 2022 Aug 15, 2022	BUY	$29.23 - $44.45 $1.28 Million - $1.95 Million	43,905 New	43,905 $1.44 Million

Others Institutions Holding PRCT

# of Institutions

266

Shares Held

38M

Call Options Held

262K

Put Options Held

257K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.17B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account